Thybetador, a potent and selective THR-β agonist: results from a phase 1 first-in-human study in healthy volunteers and participants with elevated LDL-C

thybetador (CS060380) - Cascade Pharma

https://events-distribution.easl.eu/from.storage?image=X9WvFraREucXDOc3lNmAYKLuB9pLCaHXy4yjJAF2GCKieNoRMTQ_-ZQWZCUJz_gV0

Xiangwei Hua1; Hualing Pan1; Rong Deng1; Jia Sun1; Gaihong Wang1; Guanguan Zhao1; Shengsheng Yang1; Guozhi Li1; Yun Liu2; Julia Yang1; Zhenwei Zhang1; Peter Wang1; H. Eric Xu1

Apr 19, 2026